Skip navigation
Speakers

Revenue Recognition • Gross-to-Net • IPR&D • Valuation • Leases • Transactions • Sunshine

March 17-19, 2014
  • Philadelphia, Pennsylvania

Christian Blin
Vice-President,
Head of R&D Units Finance & R&D Finance Asia
Sanofi


Lawrence Bloch, M.D., J.D.
Executive Vice President and Chief Financial Officer
Infinity Pharmaceuticals, Inc.



Ellanore Brauneis
Senior Manager
PwC


Andreas Chrysostomou
Managing Director
Duff & Phelps


Colleen Cunningham
Corporate Controller
Zoetis


James C. D’Arecca
Chief Accounting Officer
Actavis, Inc.


Christine Davine
National Director of SEC Services
Deloitte & Touche LLP


John M. DeMarrais
Life Sciences Advisory, Managing Director
KPMG LLP


Keith Donnermeyer
Partner
Deloitte & Touche LLP



Dimitri Drone
US Pharmaceutical and Life Sciences Transaction Services Leader
PwC


Mark Drozdowski
Partner, Life Sciences National Audit Leader
KPMG LLP


Martin Ebert
Vice President and Controller
Gilead Sciences


Cathy Engelbert
Partner
Deloitte & Touche LLP


Adam J. Fein, Ph.D.
President
Pembroke Consulting, Inc.;
Chief Executive Officer
Drug Channels Institute


Stephen Garbacz
Executive Director Finance
Epizyme


Tim Gordon
US Life Sciences Leader, Financial Accounting Advisory Services
Ernst & Young


Mark Guerin
Vice President,
Financial Planning and Accounting
Onconova Therapeutics, Inc.



Jay D. Hanson
Board Member
Public Company Accounting Oversight Board


Matthew Hudes
U.S. Managing Principal, Biotechnology
Deloitte Consulting LLP


Robert Keep
Managing Director
CFGI


Robert Landry
Chief Financial Officer
Regeneron


John Lanza
Partner
McGladrey


David Levi
Executive Director, U.S. Controller and Global Controls
Bristol-Myers Squibb


Francis Markey
Director, Valuation Services
Duff & Phelps


John Matthews
Principal
Monitor, Deloitte Strategy Consulting


Dana G. McFerran
Advisory Managing Director
KPMG LLP


Prateep Menon
Principal
Deloitte FAS LLP



Alison Mount
Assurance Senior Manager, Pharmaceutical & Life Sciences
PwC


Robert Owens
Assistant Controller
Bristol-Myers Squibb


Sandra Patterson
Director of SEC Reporting Technical Accounting and SOX
Gilead


Benjamin Proce
Director
PwC


Jim Quinlan
Partner
CFGI


Bryan Reasons
Chief Financial Officer
Impax Labs


Scott Requadt
Partner
Clarus Ventures



Melinda Richter
Head of Janssen Labs,
Janssen Research & Development LLC
Johnson & Johnson


Stephen Rivera
Worldwide Senior Director of Financial Compliance and Procedures
Johnson & Johnson


James B. Rosenberg
Senior Assistant Chief Accountant,
Office of Health Care and Insurance
U.S. Securities & Exchange Commission


Brent Sabatini
Director, Technical Accounting and Controls
Amgen


James Schaeffer, Ph.D.
Executive Director,
Worldwide Licensing and External Research
Merck


Jennifer Spang
Partner
PwC


Ed Stelmakh
Vice President, Finance, Clinical Development Services
Covance


Harold D. Tamayo
Corporate Vice President of Finance,
Corporate Controller
H.D. Smith



Scott Taub
Managing Director
Financial Reporting Advisors, LLC


Joseph B. Ucuzoglu
National Managing Partner, Regulatory and Professional Matters
Deloitte & Touche LLP


Suketu Upadhyay
Executive Vice President and Chief Financial Officer
Endo Pharmaceuticals


Mario van den Broek
Partner European-US Desk 
New York City, Amsterdam 
McGladrey


Pamela Yanakopulos
Partner
Capital Markets and Accounting Advisory Services (CMAAS)
PwC


Karen Young
US Pharmaceutical and Life Sciences Assurance Leader
PwC


Don Zakrowski
Vice President and Chief Accounting Officer
Eli Lilly & Company
 

Christian Blin
Vice-President,
Head of R&D Units Finance & R&D Finance Asia
Sanofi


Lawrence Bloch, M.D., J.D.
Executive Vice President and Chief Financial Officer
Infinity Pharmaceuticals, Inc.



Ellanore Brauneis
Senior Manager
PwC


Andreas Chrysostomou
Managing Director
Duff & Phelps


Colleen Cunningham
Corporate Controller
Zoetis


James C. D’Arecca
Chief Accounting Officer
Actavis, Inc.


Christine Davine
National Director of SEC Services
Deloitte & Touche LLP


John M. DeMarrais
Life Sciences Advisory, Managing Director
KPMG LLP


Keith Donnermeyer
Partner
Deloitte & Touche LLP



Dimitri Drone
US Pharmaceutical and Life Sciences Transaction Services Leader
PwC


Mark Drozdowski
Partner, Life Sciences National Audit Leader
KPMG LLP


Martin Ebert
Vice President and Controller
Gilead Sciences


Cathy Engelbert
Partner
Deloitte & Touche LLP


Adam J. Fein, Ph.D.
President
Pembroke Consulting, Inc.;
Chief Executive Officer
Drug Channels Institute


Stephen Garbacz
Executive Director Finance
Epizyme


Tim Gordon
US Life Sciences Leader, Financial Accounting Advisory Services
Ernst & Young


Mark Guerin
Vice President,
Financial Planning and Accounting
Onconova Therapeutics, Inc.



Jay D. Hanson
Board Member
Public Company Accounting Oversight Board


Matthew Hudes
U.S. Managing Principal, Biotechnology
Deloitte Consulting LLP


Robert Keep
Managing Director
CFGI


Robert Landry
Chief Financial Officer
Regeneron


John Lanza
Partner
McGladrey


David Levi
Executive Director, U.S. Controller and Global Controls
Bristol-Myers Squibb


Francis Markey
Director, Valuation Services
Duff & Phelps


John Matthews
Principal
Monitor, Deloitte Strategy Consulting


Dana G. McFerran
Advisory Managing Director
KPMG LLP


Prateep Menon
Principal
Deloitte FAS LLP



Alison Mount
Assurance Senior Manager, Pharmaceutical & Life Sciences
PwC


Robert Owens
Assistant Controller
Bristol-Myers Squibb


Sandra Patterson
Director of SEC Reporting Technical Accounting and SOX
Gilead


Benjamin Proce
Director
PwC


Jim Quinlan
Partner
CFGI


Bryan Reasons
Chief Financial Officer
Impax Labs


Scott Requadt
Partner
Clarus Ventures



Melinda Richter
Head of Janssen Labs,
Janssen Research & Development LLC
Johnson & Johnson


Stephen Rivera
Worldwide Senior Director of Financial Compliance and Procedures
Johnson & Johnson


James B. Rosenberg
Senior Assistant Chief Accountant,
Office of Health Care and Insurance
U.S. Securities & Exchange Commission


Brent Sabatini
Director, Technical Accounting and Controls
Amgen


James Schaeffer, Ph.D.
Executive Director,
Worldwide Licensing and External Research
Merck


Jennifer Spang
Partner
PwC


Ed Stelmakh
Vice President, Finance, Clinical Development Services
Covance


Harold D. Tamayo
Corporate Vice President of Finance,
Corporate Controller
H.D. Smith



Scott Taub
Managing Director
Financial Reporting Advisors, LLC


Joseph B. Ucuzoglu
National Managing Partner, Regulatory and Professional Matters
Deloitte & Touche LLP


Suketu Upadhyay
Executive Vice President and Chief Financial Officer
Endo Pharmaceuticals


Mario van den Broek
Partner European-US Desk 
New York City, Amsterdam 
McGladrey


Pamela Yanakopulos
Partner
Capital Markets and Accounting Advisory Services (CMAAS)
PwC


Karen Young
US Pharmaceutical and Life Sciences Assurance Leader
PwC


Don Zakrowski
Vice President and Chief Accounting Officer
Eli Lilly & Company